Barclays’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,973
Closed -$503K 5037
2020
Q4
$503K Hold
1,973
﹤0.01% 3229
2020
Q3
$491K Hold
1,973
﹤0.01% 3242
2020
Q2
$686K Sell
1,973
-8,160
-81% -$2.55M ﹤0.01% 3071
2020
Q1
$2.71M Buy
10,133
+280
+3% +$86.6K ﹤0.01% 2001
2019
Q4
$3.19M Buy
9,853
+5,593
+131% +$1.62M ﹤0.01% 2493
2019
Q3
$1.16M Sell
4,260
-1,447
-25% -$531K ﹤0.01% 3512
2019
Q2
$3.05M Buy
5,707
+2,567
+82% +$1.29M ﹤0.01% 2417
2019
Q1
$1.58M Buy
3,140
+833
+36% +$494K ﹤0.01% 2846
2018
Q4
$1.14M Sell
2,307
-7,660
-77% -$4.62M ﹤0.01% 2980
2018
Q3
$9.11M Buy
9,967
+3,347
+51% +$2.86M 0.01% 1321
2018
Q2
$4.85M Buy
6,620
+6,167
+1,361% +$7.11M ﹤0.01% 1750
2018
Q1
$723K Sell
453
-1,494
-77% -$1.92M ﹤0.01% 3575
2017
Q4
$1.74M Buy
1,947
+287
+17% +$170K ﹤0.01% 2562
2017
Q3
$598K Buy
1,660
+380
+30% +$119K ﹤0.01% 3445
2017
Q2
$375K Sell
1,280
-3,940
-75% -$1.14M ﹤0.01% 3806
2017
Q1
$1.84M Buy
5,220
+4,727
+959% +$1.06M ﹤0.01% 2171
2016
Q4
$91K Buy
493
+206
+72% +$41.9K ﹤0.01% 4811
2016
Q3
$74K Buy
287
+200
+230% +$51.5K ﹤0.01% 4726
2016
Q2
$18K Buy
87
+20
+30% +$4.47K ﹤0.01% 5319
2016
Q1
$13K Sell
67
-640
-91% -$123K ﹤0.01% 5393
2015
Q4
$170K Buy
707
+100
+16% +$20.6K ﹤0.01% 4032
2015
Q3
$91K Sell
607
-1,586
-72% -$281K ﹤0.01% 4681
2015
Q2
$395K Sell
2,193
-5,894
-73% -$1.01M ﹤0.01% 3666
2015
Q1
$1.33M Buy
8,087
+6,060
+299% +$1.25M ﹤0.01% 2708
2014
Q4
$456K Sell
2,027
-313
-13% -$66.9K ﹤0.01% 3947
2014
Q3
$421K Buy
2,340
+800
+52% +$153K ﹤0.01% 4092
2014
Q2
$277K Buy
1,540
+847
+122% +$150K ﹤0.01% 4507
2014
Q1
$125K Sell
693
-807
-54% -$160K ﹤0.01% 5251
2013
Q4
$248K Sell
1,500
-9,800
-87% -$1.58M ﹤0.01% 4801
2013
Q3
$1.7M Buy
11,300
+10,933
+2,979% +$2.02M ﹤0.01% 2782
2013
Q2
$64K Buy
+367
New +$56.3K ﹤0.01% 6131

Other funds holding NKTR